Related Experiment Video
Updated: Dec 27, 2025

11:31
A Chromatin Assay for Human Brain Tissue
Published on: March 21, 2008
13.3K
Neuron-specific analysis of histone modifications with post-mortem brains
Kagari Koshi-Mano1, Tatsuo Mano1, Maho Morishima2
1Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Scientific Reports
|March 1, 2020
Summary
Researchers developed a neuron-specific ChIP-seq method to analyze histone modifications in brain cells. This technique enhances understanding of neurodegeneration by focusing on neuronal epigenetic changes.
Area of Science:
- Neuroscience
- Epigenetics
- Molecular Biology
Background:
- Histone modifications regulate gene expression and cellular functions in the central nervous system.
- Postmitotic neuronal cells accumulate functional and age-dependent epigenetic changes.
- Bulk brain tissue analysis can obscure cell-specific alterations, particularly in neurons.
Purpose of the Study:
- To establish a neuron-specific ChIP-seq assay for analyzing genome-wide histone modifications.
- To overcome limitations of bulk tissue analysis in studying neuronal epigenetic states.
- To facilitate a deeper understanding of neurodegenerative diseases.
Main Methods:
- Development of a novel neuron-specific ChIP-seq (Chromatin Immunoprecipitation sequencing) assay.
- Application of the assay to post-mortem brain tissue.
- Analysis of genome-wide histone modification distribution specifically within neuronal cells.
Main Results:
- Successful enrichment of neuronal epigenetic information with high reproducibility.
- Achieved a high signal-to-noise ratio in the analysis.
- Demonstrated the feasibility of studying neuronal histone modifications from post-mortem brains.
Conclusions:
- The developed neuron-specific ChIP-seq method accurately captures neuronal epigenetic landscapes.
- This technique provides a valuable tool for investigating age-dependent and disease-specific changes in neuronal chromatin.
- It offers a potential breakthrough for understanding the mechanisms underlying neurodegeneration.

